Benzac 5

Quick links to important sections

Benzac 5

Selected form

Medically reviewed

Marina Burgos

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Benzac 5

Quick Facts

Property Description
Active ingredient Benzoyl Peroxide (BPO)
Form Cutaneous Gel (Water-based)
Pharmacological class Anti-acne agent, Keratolytic agent
General purpose Management of mild to moderate acne
Origin Synthetic Organic Peroxide

What Kind of Medicine is Benzac 5?

Benzac 5 is a proprietary brand name for a topical preparation that uses the single active ingredient, Benzoyl Peroxide (BPO), intended solely for external application to the skin. This substance is classified as a synthetic organic peroxide compound, with its primary therapeutic function placing it within the high-level pharmacological class of Anti-acne agents. The product is defined as a monotherapy solution, relying exclusively on the effect of BPO to address acne vulgaris. Benzoyl Peroxide in concentrations up to 10% is classified as Generally Recognized as Safe and Effective (GRASE) for over-the-counter acne management.

Composition, Form, and General Purpose

This specific preparation is formulated as a non-greasy Cutaneous Gel, utilizing a water-based gel vehicle, a distinctive feature often preferred for application on skin prone to excess oil. The 5% concentration of Benzoyl Peroxide defines this product's strength within the available range of BPO topical treatments. This concentration is recognized for balancing efficacy with patient tolerability, particularly in treating typical acne breakouts in adolescents and adults. The general purpose of this topical application is to reduce the severity of existing blemishes and help discourage the formation of new lesions.

Core Principles of Action at a High Level

The function of Benzoyl Peroxide is rooted in two medically recognized principles: powerful antimicrobial activity and comedolytic action. It acts as an oxidizing agent, exerting a direct bactericidal effect against Cutibacterium acnes, the bacterium closely associated with acne development. Concurrently, it functions as a Keratolytic agent, promoting the desquamation (shedding of dead skin cells) necessary to unblock pores.

Regulatory References

  1. Benzoyl Peroxide Mechanism of Action

What side effects are possible with Benzac 5?

Possible Side Effects and Safety Information

The safety profile for this medication is primarily characterized by frequent, localized skin reactions at the application site and the rare potential for serious systemic allergic reactions.

Documented Adverse Reactions

The most commonly reported adverse effects are typically limited to the skin and are often noted in clinical trials and regulatory documents as follows:

Frequency Classification Side Effect (Skin and Subcutaneous Tissue Disorders)
Very Common (ge 1/10) Dry skin, Erythema (redness), Skin exfoliation (peeling), Burning sensation of the skin.
Common (ge 1/100 to <1/10) Pruritus (itching), Skin pain (stinging), Skin irritation (irritant contact dermatitis).
Uncommon (ge 1/1,000 to <1/100) Allergic contact dermatitis.
Not Known (Post-marketing) Serious hypersensitivity reactions, Anaphylaxis, Angioedema (swelling of the face, tongue, or throat).

Serious adverse reactions, though rare, include signs of severe hypersensitivity such as anaphylaxis (a life-threatening allergic response) and angioedema (significant swelling of the face, eyes, or throat), which require immediate medical attention.

Safety Restrictions and Contraindications

Official regulatory documents require specific limitations on use to minimize risk:

  • Contraindications: This product should not be used by individuals with a history of hypersensitivity or allergy to its active ingredient or any of its components.
  • Avoidance: Contact with the eyes, lips, mouth, and mucous membranes must be avoided. The product should not be applied to damaged or broken skin.
  • Sun Exposure: Use of this product may increase the skin's sensitivity to sunlight. Excessive or unnecessary exposure to natural or artificial UV light (e.g., sunlamps, tanning beds) should be avoided.
  • Other Products: Co-use with other topical medications that have strong drying, desquamative (peeling), or irritant effects may increase the risk of skin irritation.
  • Discoloration: The active ingredient may bleach or discolor hair and dyed fabrics.

Population-Specific Safety

For pregnant or breastfeeding women, regulatory guidance suggests that use should only occur if clearly needed, with caution advised. It is not known if the active substance is excreted in human milk, and application to the chest area should be avoided in nursing women.

Overdose and Emergency Response

Overdose and When to Seek Help

Overdose involving topical Benzoyl Peroxide is officially classified into two distinct regulatory scenarios: acute local intolerance and rare, severe systemic hypersensitivity. Systemic toxicity from absorption is not a primary concern due to the product’s design.


Documented Manifestations and Severe Outcomes

Excessive application or misuse may lead to severe local intolerance, documented by signs such as severe redness, burning, peeling, or swelling at the application site. The presence of systemic hypersensitivity constitutes the most severe outcome. Documented manifestations include hives, itching, swelling of the eyes, face, lips, or tongue, throat tightness, or difficulty breathing. Such reactions are considered serious and may involve compromised respiratory or cardiovascular function, potentially requiring hospital monitoring.


Official Emergency Actions

Regulatory guidance strictly mandates action based on the symptom type. If severe local irritation occurs, the product must be stopped immediately. If any signs of a serious allergic reaction (e.g., throat swelling or trouble breathing) are observed, the individual must seek emergency medical attention immediately. In cases of accidental ingestion, a Poison Control center should be contacted. No specific antidote is officially documented; therefore, management is limited to symptomatic and supportive treatment. Thorough rinsing with water is specified for accidental contact with mucous membranes.

Therapeutic Uses of Benzac 5

What Benzac 5 Treats: Main Uses and Benefits

Benzac 5 is commonly used to manage the symptomatic manifestations of mild to moderate acne vulgaris. This therapeutic domain is relevant in clinical contexts involving initial treatment approaches and involves addressing the full spectrum of lesions. This includes the inflamed, reddened spots such as papules and pustules, and the non-inflammatory forms like blackheads and whiteheads (comedones). Its use may support the easing of the overall symptom burden by contributing to the management of these existing blemishes during a breakout.


Quick Fact: Relief for Acne Symptoms

Category Typical Context
Symptom Cluster Inflammatory and non-inflammatory skin lesions
Severity Relevance Mild to moderate symptomatic episodes
Primary Benefit Supports the management of lesion clusters and recurrent symptoms

Beyond addressing immediate symptoms, a key therapeutic benefit contributes to managing recurrent symptomatic episodes. The medication is relevant for individuals experiencing these conditions, and may assist with reducing the frequency of new lesion formation. This function contributes to maintaining a sense of stability and supports general well-being during symptomatic phases. As such, the product is commonly applied in clinical settings as a first-line topical treatment for initial acne management. It may also be part of symptomatic management in combination regimens, where it assists with maintaining functional stability during periods of heightened symptoms alongside other therapies.

Eligibility and Restrictions for Use

Who Can and Cannot Use Benzac 5?

Regulatory authorities define the eligibility profile for Benzac 5 (Benzoyl Peroxide 5% Gel) based on age, medical history, and current physiological status.


Approved and Restricted Populations

  • Approved Age Group: The medicine is intended for use in adults and adolescents aged 12 years and over. Safety and effectiveness have not been established in children younger than 12 years of age.
  • Pregnancy and Lactation: Use during pregnancy or while breastfeeding is generally not recommended unless considered clearly necessary and should be medically supervised. Nursing mothers must avoid application to the chest area.
  • Organ Impairment: The product has not been studied in patients with renal (kidney) or hepatic (liver) impairment; eligibility guidance is limited.

Absolute Contraindications

  • The medicine is contraindicated in individuals with a known hypersensitivity (allergy) to Benzoyl Peroxide or to any of the specific excipients in the gel formulation.
  • The product must not be applied to skin that is damaged, inflamed, cut, or affected by eczema or sunburn. Application to mucous membranes, such as the eyes or mouth, is also prohibited.

What should I know about interactions with other medicines?

The official interaction profile for topical Benzoyl Peroxide is determined by its minimal systemic absorption, which is consistent with the absence of documented systemic drug-drug interactions. Regulatory information focuses almost exclusively on local, application-site interactions.

Interaction Classification Relevant Interacting Agents/Restrictions
Pharmacokinetic Interactions None documented with systemic medicines, and no effects on CYP-mediated metabolism are reported.
Pharmacodynamic/Chemical Effects Topical Retinoids (e.g., Tretinoin), Topical Dapsone Gel, and other desquamating or highly irritant agents.

Official Interaction Statements:

  • Topical Retinoids: Concurrent application with topical retinoids, such as Tretinoin, may lead to the oxidative degradation of the retinoid molecule and may cause excessive skin irritation and dryness.
  • Topical Dapsone Gel: Co-administration with topical Dapsone gel may result in a temporary local yellow or orange discoloration of the skin and facial hair. Timing separation is required to mitigate this effect.
  • Other Topical Treatments: The concurrent use of other topical agents with keratolytic or strong drying effects is restricted due to the increased likelihood of cumulative skin irritation and peeling.

Connection to the overall interaction profile: The official interaction structure is defined by the need to manage these documented local chemical and pharmacodynamic constraints. This requires timing separation for specific topical agents and adherence to a general regulatory restriction on the simultaneous use of multiple local irritants. The lack of documented systemic interactions simplifies the co-administration profile with oral medicines.

Mechanism of Action

Antimicrobial Oxidizing Action

The drug acts as an oxidizing agent, releasing free-oxygen radicals that penetrate the pores and rapidly disrupt the cell membranes and metabolic functions of Cutibacterium acnes bacteria. This chemical interaction leads to the destruction of the microbial population within the pilosebaceous unit, resulting in a physiological reduction of bacterial load and the primary stimulus for inflammation.


Keratolytic and Desquamation Mechanism

The compound exerts a keratolytic effect by influencing the cell-shedding process (desquamation) of keratinocytes lining the hair follicle. By promoting the faster and more efficient shedding of dead skin cells, the mechanism alters the follicular environment, reducing the accumulation of sebum and cellular debris. This supports a clearance of follicular obstructions.


Anti-inflammatory Pathway Influence

A related mechanism involves the influence of the drug on the local inflammatory cascade. The substantial reduction in the bacterial load—a key stimulus—decreases the local production of pro-inflammatory mediators. This results in a corresponding change in the localized immune response, which involves a reduction in inflammatory mediators.

Dosage and Administration Information

Instruction Map: How to use Benzac 5 — Official Administration Guidelines

Benzac 5% is an external medication with administration governed by protocols that specify the route, frequency, and application technique. The protocol requires that the use remain strictly descriptive of the official instructions.

Feature Guideline (Strictly Label-Based)
Route of Administration Topical (Cutaneous) administration only.
Dosing Schedule Application involves a thin layer covering the entire affected area. The initial frequency is once daily, with a gradual increase to two or three times daily permissible if tolerated.
Preparation Requirements The application site must be thoroughly cleaned and dried before the gel is applied.
Age-Group Rules The medication is intended for use in adults and adolescents aged 12 years and over. Use for younger children must be determined by a healthcare provider.

The official use protocol requires a titratable daily frequency that begins conservatively to gauge patient tolerance, especially for sensitive skin where evening-only application is sometimes specified. Standard clinical data suggests that the duration of treatment generally requires between eight and twelve weeks to achieve the maximum intended effect, although initial changes are often observed earlier. The entire use protocol is defined by strict application constraints, including the mandatory avoidance of contact with the eyes and mucous membranes, alongside the explicit warning that the product may discolor or bleach fabrics and hair. The administration process is defined by these instructions to standardize drug delivery and adherence across the treated population.

Recent Clinical Evidence

Benzac 5: Recent Clinical Evidence

Clinical research has focused on the application of Benzoyl Peroxide (BPO), the active ingredient in Benzac 5, for managing mild to moderate acne vulgaris. BPO is studied for its action in inhibiting the growth of Cutibacterium acnes (C. acnes) and its association with a reduction in both inflammatory and non-inflammatory acne lesions.


Efficacy in Lesion Count Reduction

Large-scale clinical trials have evaluated the effect of BPO 5% on acne lesion counts. A comprehensive meta-analysis incorporating multiple randomized controlled trials reported that BPO was associated with a statistically significant reduction in inflammatory lesion counts (papules and pustules) compared to a placebo after 8 to 12 weeks of treatment. The reduction observed for non-inflammatory lesions (comedones) was also noted but typically to a lesser degree.

Comparison to Other Topical Agents

Comparative studies have been conducted to evaluate BPO 5% against other commonly used topical treatments. In trials evaluating BPO monotherapy against topical retinoid monotherapy, findings suggested that both treatments demonstrated comparable improvements in reducing inflammatory lesion counts over the initial treatment period. However, research has also explored combination treatments, finding that combining BPO with other agents, such as topical antibiotics or retinoids, was associated with greater efficacy and a faster onset of observable change in lesion counts compared to BPO used alone.


Tolerability Profile

Observed adverse events in clinical trials were primarily related to local skin reactions. The most frequently reported events were mild to moderate dryness, erythema (redness), and peeling at the application site. These effects were generally described as transient, often decreasing in severity as treatment continued.

Key Studies & References

  1. Meta-analysis of research on acne reveals that oral isotretinoin, followed by topical antibiotic, benzoyl peroxide and retinoid, are most effective treatments

Frequently Asked Questions (FAQ)

Common questions about Benzac 5 (FAQ)


Q: How quickly does Benzac 5 start to show results?

A: Clinical trial data related to Benzoyl Peroxide products often evaluates initial changes in acne lesion counts as early as 2 to 4 weeks after treatment begins. While initial observable changes may occur during this period, achievement of the full effect described in official documents requires ongoing and consistent application.


Q: What is the difference between irritation and an allergic reaction to Benzac 5?

A: The official safety profile distinguishes between common irritation and a rare allergic reaction. Irritation is a local skin effect that may involve expected redness, dryness, or peeling. A serious allergic reaction, known as hypersensitivity, is rare but includes severe symptoms like difficulty breathing, throat tightness, or significant swelling of the face, eyes, or tongue.


Q: Does Benzac 5 interact with other skincare ingredients like retinoids or Vitamin C?

A: Regulatory warnings primarily focus on local application-site interactions. Specifically, concurrent application with other topical irritants, such as retinoids, may lead to excessive irritation. Review of systemic interaction data suggests no documented interaction between topical Benzoyl Peroxide and Vitamin C.


Q: Can I use Benzac 5 alongside a topical antibiotic cream?

A: Topical Benzoyl Peroxide is often found in combination with topical antibiotics in certain regulated products. However, using BPO alongside other topical acne medications may increase the risk of skin irritation and dryness, and the general regulatory restriction on the simultaneous use of multiple local irritants applies.


Q: Is Benzac 5 safe to use during pregnancy?

A: Regulatory guidance suggests that topical Benzoyl Peroxide is generally considered acceptable for use during pregnancy due to low systemic absorption into the bloodstream. Official guidance notes that use should only occur if clearly needed, with caution advised.


Q: Is using Benzac 5 safe while breastfeeding?

A: It is generally considered acceptable to use while breastfeeding because systemic absorption is low, meaning it is unlikely to pass into breast milk in significant amounts. However, application to the chest area must be avoided, as specified in regulatory information, to prevent the infant from direct contact with the medication.


Q: Does Benzac 5 lose effectiveness after the container is opened for a long time?

A: Yes. According to the official handling and storage instructions, the product should typically be discarded after three months from the date it is first opened. This timeline is specified to help ensure product stability and effectiveness.


Q: How long is Benzac 5 typically used for before seeing the full effect?

A: Regulatory information and clinical guidelines suggest that the duration of treatment generally requires between eight and twelve weeks of consistent use. This time frame is typically needed to achieve the maximum intended effect on the skin.


Q: How does the concentration of Benzac 5 compare to other available treatments?

A: The active ingredient, Benzoyl Peroxide, is available in concentrations ranging from 2.5% up to 10% in various products. The 5% concentration of Benzac 5 is widely recognized for balancing efficacy with tolerability.


Q: Is Benzac 5 the same as other benzoyl peroxide products?

A: Benzac 5 is a specific brand name for a 5% Benzoyl Peroxide gel. While the active ingredient and strength may be the same as other BPO 5% products, the inactive ingredients (excipients) used to formulate the gel, such as stabilizers or vehicle, can vary by brand and manufacturer.


Q: Is it possible for acne to look worse when first starting Benzac 5?

A: Initial use of BPO products may be accompanied by increased dryness, redness, burning, or peeling—all of which are common local skin reactions. These effects can sometimes be mistaken for worsening acne. Official labeling advises that if these effects become bothersome, the frequency of application should be reduced.


Q: Can Benzac 5 help with different types of acne, like blackheads or cysts?

A: The medication's mechanism of action addresses both inflammatory (e.g., papules and pustules) and non-inflammatory acne lesions. Official indications confirm its use for reducing lesions like blackheads and whiteheads by promoting the unblocking of pores.


Q: What should be done if Benzac 5 accidentally gets into the eyes, nose, or mouth?

A: The product is for external use only, and contact with mucous membranes must be avoided. If Benzac 5 accidentally gets into the eyes, nose, mouth, or other mucous membranes, official administration instructions require rinsing the area well with water.


Q: Is Benzac 5 available over-the-counter or does it require a prescription?

A: The active ingredient, Benzoyl Peroxide 5%, is recognized in the FDA monograph as a human Over-The-Counter (OTC) drug. This means it is typically available for purchase without requiring a prescription from a healthcare provider.


Q: Is it required to use a specific moisturizer while using Benzac 5?

A: The product instructions do not mandate the use of a specific moisturizer. However, because common side effects include dryness and peeling, the use of a mild moisturizer is generally noted as helpful to manage and alleviate these skin reactions.


Q: Does Benzac 5 have an effect on skin oiliness or sebum production?

A: Studies on the drug's mechanism of action indicate that in addition to its antimicrobial and keratolytic properties, its influence on the follicular environment is associated with a decrease in the accumulation of sebum (oil) and keratin around the hair follicles.


Q: What is the difference between the gel and wash formulations of Benzac 5?

A: The primary difference lies in the intended use and contact time. The gel formulation is designed as a leave-on treatment that remains on the skin for long-term action, while the wash formulation is intended as a cleanser with a shorter contact time before rinsing.


Q: Is there any risk related to the long-term storage of Benzac 5 products?

A: Regulatory information and stability research have investigated the potential for Benzoyl Peroxide to degrade. Evidence indicates that Benzoyl Peroxide products, especially when stored at elevated temperatures, can slowly form trace amounts of benzene, which is subject to specific regulatory safety limits.


Q: Why is consistency of application important for Benzac 5?

A: The medication functions as a potent bactericide that acts against the bacteria associated with acne development. Consistent application as directed is necessary to maintain the required continuous destruction and reduction of the bacterial population over the full course of treatment.


Q: Are there any known interactions between Benzac 5 and food or alcohol?

A: Regulatory documents report the absence of documented systemic drug-drug interactions with food or alcohol. This is expected because the medication is applied topically and has minimal absorption into the bloodstream.


Q: What is the recommended approach if the acne does not improve after one month of using Benzac 5?

A: Regulatory labeling defines that stopping use and consulting a healthcare provider is the specified protocol if the skin condition worsens or if no improvement is observed within a defined short trial period (often listed as 4 to 7 days).


Q: Does the application of Benzac 5 at night differ from daytime application?

A: The labeling allows for applications to be titrated (adjusted) throughout the day. Many healthcare protocols may suggest application in the evening due to the product's potential to increase sensitivity to sunlight and to manage irritation during daytime activities.


Q: Can Benzac 5 cause a feeling of skin tightness?

A: Yes. The feeling of skin tightness is associated with the very common side effect of dry skin or skin exfoliation (peeling). These effects are widely reported in clinical trials and safety documentation for Benzoyl Peroxide products.


Q: Can I apply Benzac 5 to a larger area of the face or only on individual spots?

A: The administration instructions specify that a thin layer should be applied to cover the entire affected area that is prone to acne, rather than only focusing on individual existing blemishes or spots.


Q: What is the recommendation for sun exposure while using Benzac 5?

A: Because the product can increase sensitivity to sunlight, exposure to natural or artificial UV light should be minimized or avoided. Official guidance notes that the use of sunscreen and protective clothing is expected when sun exposure cannot be avoided.


Q: Does Benzac 5 contain any parabens or fragrances?

A: The full list of inactive ingredients, or excipients, is detailed in the specific product's regulatory labeling (DailyMed or SmPC). The inclusion of ingredients like parabens or fragrances varies by manufacturer and specific brand formulation.

How should Benzac 5 be stored and disposed of?

How to Store and Dispose of Benzac 5

Official regulatory documents define strict storage and disposal requirements for Benzac 5 (Benzoyl Peroxide) gel to maintain its stability and ensure safety.

Requirement Area Instructions from Official Labeling
Temperature Control Store the gel at controlled room temperature, typically between 15 C and 30 C (59 F and 86 F). Do not allow the product to freeze and keep it away from heat and flame.
Protection & Handling The container must be kept tightly closed and stored away from direct light and moisture. After the first opening, the product should typically be discarded within three months.
Child Safety As with all medicines, it must be kept strictly out of the reach of children.
Disposal Rules Expired or unused Benzac 5 should not be disposed of in household trash, down the sink, or in the toilet. Return the medicine to a pharmacy or official collection point for proper disposal.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Benzac 5 found in:

A-Z Index: